INDIUM IN-111 IBRITUMOMAB TIUXETAN
UNII S9U4ZR2W8V

Substance Identification & Data

This profile provides standardized clinical and technical data for Indium In-111 Ibritumomab Tiuxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) S9U4ZR2W8V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

S9U4ZR2W8V

CAS Registry Number

N/A

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

INDIUM IN-111 IBRITUMOMAB TIUXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C2579

National Cancer Institute reference terminology for clinical and research data.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Indium In-111 Ibritumomab Tiuxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.